A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II).
暂无分享,去创建一个
Y. Miyagi | T. Yoshikawa | J. Sakamoto | K. Tanabe | H. Nemoto | S. Morita | Y. Rino | N. Hirabayashi | R. Fukushima | Masazumi Takahashi | J. Kawada | Michiya Kobayashi | N. Oriuchi | K. Yamaguchi | A. Tsuburaya | K. Yamaguchi | K. Nishikawa | T. Aoyama | T. Matsui | S. Yoshino | Y. Miyashita | Seiji Sato | J. Nakajima | Kazuya Yamaguchi